Alnylam Pharmaceuticals, Inc. (MM) Stock Price - ALNY

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$40.31
SMALL CAP PRO
Monthly Subscription
for only
$43.59
ULTIMATE TRADER
Monthly Subscription
for only
$65.99
VAT not included
After Hours
Last Trade
Last: $ 42.25 ◊ 0.00 (0.00%)
Company Name Stock Ticker Symbol Market Type ISIN
Alnylam Pharmaceuticals, Inc. (MM) ALNY NASDAQ Common Stock US02043Q1076
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded DELAYED
  +1.445 +3.54% 42.25 43.58 41.11 41.29 40.805 20:00:00
Bid Price Ask Price Spread Spread % News
35.00 43.14 8.14 18.87% 2 -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
10,086.00 1,401,075.00 $ 42.34 $ 59.32M 1.51M 31.38 - 98.00
Last Trade Time Type Quantity Stock Price Currency
17:34:55 formt 20,000.00 $42.25 USD

Alnylam Pharmaceuticals, Inc. (MM) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 3.62B 85.72M $ -290.07M -3.45 0.00 50.93M
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
10.13M $ 0.00 0.00% 35.44k 95.80%

more financials information »

Alnylam Pharmaceuticals, Inc. (MM) News

Date Time Source News Article
12/09/201616:13Edgar (US Regulatory)Statement of Ownership (sc 13g)
12/09/201612:43Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)
12/08/201616:00Business WireAlnylam to Webcast R&D Day
12/05/201616:56Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)
12/05/201613:00Business WireAlnylam Presents Updated Results from Phase 1/2 Study of..
12/04/201612:00Business WireAlnylam Reports Positive Interim Clinical Results for..
12/03/201612:02Business WireAlnylam Reports Positive Interim Phase 1 Results for..

Historical ALNY Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week41.6043.5839.1841.17261M2M1M0.651.56%
1 Month45.3652.8539.1844.7088524k3M1M-3.11-6.86%
3 Months73.6780.1131.3841.6073316k17M2M-31.42-42.65%
6 Months64.4680.1131.3849.2685266k17M1M-22.21-34.46%
1 Year94.5998.0031.3857.2307164k17M1M-52.34-55.33%
3 Years59.68140.0031.3875.3414017M831k-17.43-29.21%
5 Years7.96140.007.6162.3725017M698k34.29430.78%

Alnylam Pharmaceuticals, Inc. (MM) Description

Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutics based on RNA interference, which is a naturally occurring biological pathway within cells for selectively silencing and regulating the expression of specific genes.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20161210 22:22:12